Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shi Yong Neo

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Theranostics|December 11, 2024
Revolutionizing cancer treatment: the emerging potential and potential challenges of <i>in vivo</i> self-processed CAR cell therapyRuijie Lv, Yanting Guo, Weici Liu, et al.
Biology|April 28, 2023
Mitochondrial Dysfunction in CD4+ T Effector Memory RA+ CellsMarie Strickland, Salanne Lee, Shi Yong Neo, et al.
Oncoimmunology|March 24, 2025
Cellular and secretome profiling uncover immunological biomarkers in the prognosis of renal cell carcinoma patientsLe Tong, Veronika Kremer, Shi Yong Neo, et al.
The Journal of Clinical Investigation|July 17, 2020
Thioredoxin activity confers resistance against oxidative stress in tumor-infiltrating NK cellsYing Yang, Shi Yong Neo, Ziqing Chen, et al.
Cancer Immunology Research|April 28, 2025
Adaptive NK Cells Exhibit Tumor-Specific Immune Memory and Cytotoxicity in Ovarian CancerYizhe Sun, Andrea Rodgers Furones, Okan Gultekin, et al.
Cancer Immunology, Immunotherapy : CII|July 30, 2025
VHL restoration in clear cell renal cell carcinoma improves NK cell infiltration and functionLe Tong, Apple Hui Min Tay, Weiyingqi Cui, et al.
Journal for Immunotherapy of Cancer|October 25, 2022
Tumor MHC class I expression alters cancer-associated myelopoiesis driven by host NK cellsShi Yong Neo, Xu Jing, Le Tong, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 27, 2022
Breast cancer patient-derived whole-tumor cell culture model for efficient drug profiling and treatment response predictionXinsong Chen, Emmanouil G Sifakis, Stephanie Robertson, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 8, 2024
Natural killer cells drive 4-1BBL positive uveal melanoma towards EMT and metastatic diseaseShi Yong Neo, Mariana M S Oliveira, Le Tong, et al.
Cancers|April 3, 2021
CD11c-CD8 Spatial Cross Presentation: A Novel Approach to Link Immune Surveillance and Patient Survival in Soft Tissue SarcomaYanhong Su, Panagiotis Tsagkozis, Andri Papakonstantinou, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Theranostics|December 11, 2024
Revolutionizing cancer treatment: the emerging potential and potential challenges of <i>in vivo</i> self-processed CAR cell therapyRuijie Lv, Yanting Guo, Weici Liu, et al.
Biology|April 28, 2023
Mitochondrial Dysfunction in CD4+ T Effector Memory RA+ CellsMarie Strickland, Salanne Lee, Shi Yong Neo, et al.
Oncoimmunology|March 24, 2025
Cellular and secretome profiling uncover immunological biomarkers in the prognosis of renal cell carcinoma patientsLe Tong, Veronika Kremer, Shi Yong Neo, et al.
The Journal of Clinical Investigation|July 17, 2020
Thioredoxin activity confers resistance against oxidative stress in tumor-infiltrating NK cellsYing Yang, Shi Yong Neo, Ziqing Chen, et al.
Cancer Immunology Research|April 28, 2025
Adaptive NK Cells Exhibit Tumor-Specific Immune Memory and Cytotoxicity in Ovarian CancerYizhe Sun, Andrea Rodgers Furones, Okan Gultekin, et al.
Cancer Immunology, Immunotherapy : CII|July 30, 2025
VHL restoration in clear cell renal cell carcinoma improves NK cell infiltration and functionLe Tong, Apple Hui Min Tay, Weiyingqi Cui, et al.
Journal for Immunotherapy of Cancer|October 25, 2022
Tumor MHC class I expression alters cancer-associated myelopoiesis driven by host NK cellsShi Yong Neo, Xu Jing, Le Tong, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 27, 2022
Breast cancer patient-derived whole-tumor cell culture model for efficient drug profiling and treatment response predictionXinsong Chen, Emmanouil G Sifakis, Stephanie Robertson, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 8, 2024
Natural killer cells drive 4-1BBL positive uveal melanoma towards EMT and metastatic diseaseShi Yong Neo, Mariana M S Oliveira, Le Tong, et al.
Cancers|April 3, 2021
CD11c-CD8 Spatial Cross Presentation: A Novel Approach to Link Immune Surveillance and Patient Survival in Soft Tissue SarcomaYanhong Su, Panagiotis Tsagkozis, Andri Papakonstantinou, et al.
Pageof 3